Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01657877 · ClinicalTrials.gov registry record · Phase 2

Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice

A Phase 2 study of Caries, sponsored by GlaxoSmithKline.

Completed
Registry status
Phase 2
Development phase
100
Enrollment target
1
Study location

NCT01657877: Completed Phase 2 study of Caries, sponsored by GlaxoSmithKline.

NCT01657877 is a Phase 2 study of Caries that has completed, run by GlaxoSmithKline. The registered enrollment target is 100 participants, above the 46-participant average among 7 other Caries trials with a reported enrollment target (117% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01657877, a Phase 2 study of Caries, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
Phase 2
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

In situ study to compare treatment effect on enamel remineralization potential, measured by surface microhardness recovery (SMHR) and Enamel Fluoride Uptake (EFU). The study will explore the efficacy of an experimental sodium monofluorophosphate (SMFP) dentifrice containing calcium sodium phosphosilicate (CSP) in comparison to an experimental SMFP only dentifrice.

Primary Outcome

Percent SMH recovery (SMHR) was calculated from hardness values of enamel specimens at baseline (B), after in-situ hardening (R) and after first demineralization challenge (D1) using formula: \[(D1-R)/ (D1-B)\]\*100. A greater percentage change in SMHR represents a better remineralisation and hence a better outcome.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Calcium sodium phosphosilicate
  • DRUG Sodium monoflurophosphate

Study Locations (1)

Indiana

  • Indiana University School of Dentistry - Indianapolis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2012-05
Est. Completion 2013-06
Phase Phase 2
GlaxoSmithKline

1,345 total trials

What the finished NCT01657877 record still lists

NCT01657877 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 46-participant average among 7 other Caries trials with a reported enrollment target (117% higher).

The record links to 1 condition, with Caries appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT01657877 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT01657877 about?

NCT01657877 is a clinical study titled "Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice". In situ study to compare treatment effect on enamel remineralization potential, measured by surface microhardness recovery (SMHR) and Enamel Fluoride Uptake (EFU). The study will explore the efficacy of an experimental sodium monofluorophosphate (SMFP) dentifrice containing calcium sodium phosphosil...

What is the current status of trial NCT01657877?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2012-05. Estimated completion is 2013-06.

What conditions does trial NCT01657877 study?

This clinical trial studies the following conditions: Caries.

What interventions are being tested in trial NCT01657877?

The interventions under investigation include: Placebo (DRUG), Calcium sodium phosphosilicate (DRUG), Sodium monoflurophosphate (DRUG).

Who is sponsoring clinical trial NCT01657877?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01657877 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01657877, the US trial registry maintained by the National Library of Medicine. NCT01657877 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.